Michael Burns

Vice President at Zylö Therapeutics

With over 40 years in the international pharmaceutical and health care industries, Dr. Michael Burns has extensive senior and general management experience in FDA-regulated manufacturing and laboratory operations, research and development, corporate and business development, licensing, acquisitions, sales and marketing. Most recently, Dr. Burns served as President and Chief Operating Officer of Michigan-based Ferndale Pharma Group, Inc., which develops, manufactures and markets a variety of prescription and non-prescription dermatological and related products. He held several executive positions during his 27-year tenure there. Dr. Burns was also Chief Executive Officer of Repromedix Corp., a Massachusetts-based company specializing in the diagnosis of male and female infertility. He is also on the board and serves as scientific advisor to SciTech LLC, a Michigan-based enterprise that performs translational research and development. SciTech is actively developing new drugs for solid tumors, non-melanoma skin cancers, and pre-cancers. A native of Britain and Germany, Dr. Burns has a B.Sc. Honors degree from the University of Reading in Physiology, Biochemistry & Chemistry and a Ph.D. in Pharmacology from the Universities of Cambridge and Nottingham.


Org chart

Sign up to view 0 direct reports

Get started